These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35915746)

  • 1. Are private equity and venture capital helping small and medium-sized enterprises during the COVID-19 pandemic? Evidence from China.
    Yang S
    Econ Anal Policy; 2022 Dec; 76():1-14. PubMed ID: 35915746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Venture Capital on Enterprise Benefit According to the Heterogeneity of Human Capital of Entrepreneur.
    Jin X; Zheng P; Zhong Z; Cao Y
    Front Psychol; 2020; 11():1558. PubMed ID: 32754091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Covid-19 impacts the financing in SMEs: Evidence from private firms.
    Yao Z; Liu Y
    Econ Anal Policy; 2023 Jun; ():. PubMed ID: 38620097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venture capital, control rights, and family enterprise growth.
    Pang X; Liu L
    PLoS One; 2021; 16(8):e0256318. PubMed ID: 34407119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Financial Asset Allocation, Leverage Ratio, and Risk-Taking of Small- and Medium-Sized Enterprises in China: Taking Environment-Related Industries as an Example.
    Chen Q
    J Environ Public Health; 2022; 2022():2431428. PubMed ID: 35733979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of venture capital funds with foreign limited partners investment on enterprise internationalization: evidence from China.
    Feng T; Guo L; Dong J; Wang H
    Heliyon; 2022 Dec; 8(12):e12281. PubMed ID: 36578392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the influence of COVID-19 on the growth of China's small and medium-sized construction enterprises.
    Wang W; Lin W; Bao Z; Dai X; Lin Q
    PLoS One; 2022; 17(6):e0266315. PubMed ID: 35657961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Venture Capital in Enterprise Innovation Under Psychological Capital and Heterogeneity of Entrepreneur Capital.
    Zhang C; Mao D; Wang M
    Front Psychol; 2020; 11():1704. PubMed ID: 32754105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State equity participation and financing constraints of private enterprises in China: Based on the competitive pressure perspective.
    Xiao Q
    PLoS One; 2023; 18(11):e0292817. PubMed ID: 37967071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Budgets of Technology-Based SMEs From the Perspective of Sustainability and Big Data.
    Zhang G; Wang T
    Front Public Health; 2022; 10():861074. PubMed ID: 35602131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel enterprises digital transformation influence empirical study.
    Sun X; Sun W; Wang Z
    PLoS One; 2024; 19(1):e0296693. PubMed ID: 38215168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling Latent Structure of Venture Capital Syndication Networks.
    Gu W; Yang A; Lu L; Li R
    Entropy (Basel); 2022 Oct; 24(10):. PubMed ID: 37420525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can venture capital shareholding improve M&A performance? An empirical study based on Chinese GEM-listed companies.
    Chao K; Wang M; Hu Y; Wang S
    PLoS One; 2024; 19(8):e0308932. PubMed ID: 39146381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How innovation funding leads enterprises to engage in research and development: Small and medium enterprises' perspective.
    Sun H; Yang X; Tang X; Peng F
    PLoS One; 2023; 18(7):e0289166. PubMed ID: 37490503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital inclusive finance, financial mismatch and the innovation capacity of small and medium-sized enterprises: Evidence from Chinese listed companies.
    Li W; Pang W
    Heliyon; 2023 Feb; 9(2):e13792. PubMed ID: 36865464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on the impact of COVID-19 on Chinese small and medium-sized enterprises: Evidence from Beijing.
    Ma Z; Liu Y; Gao Y
    PLoS One; 2021; 16(12):e0257036. PubMed ID: 34882688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different government subsidies on total-factor productivity: Evidence from private listed manufacturing enterprises in China.
    Wang D; Sun Y
    PLoS One; 2022; 17(1):e0263018. PubMed ID: 35100316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Enterprise Financial Risk and R&D Investment Under the Influence of the COVID-19.
    Li X; Cheng B; Li Y; Duan J; Tian Y
    Front Public Health; 2022; 10():910758. PubMed ID: 35991059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shareholder heterogeneity, financing constraints, and organizational resilience: Mixed-ownership reform in Chinese private enterprises.
    Zhang J; Cai L; Gao Y
    Heliyon; 2024 Aug; 10(16):e36380. PubMed ID: 39247365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.